Previous Close | 0.0235 |
Open | 0.0245 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 0.0224 - 0.0245 |
52 Week Range | 0.0131 - 0.1150 |
Volume | |
Avg. Volume | 415,001 |
Market Cap | 12.746M |
Beta (5Y Monthly) | 1.35 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0000 |
Earnings Date | Apr 26, 2021 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
LOS ANGELES and DESERT HOT SPRINGS, Calif., May 09, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Grapefruit USA, Inc. (OTCQB: GPFT) (“Grapefruit” or the “Company”), an innovative California-based cannabiotech company, is providing an update on its previously announced execution of a Memorandum of Understanding (“MOU”) with Diagnostic Lab Corporation of Englewood Cliffs, New Jersey, (“DLC”) a diversified food and agriculture safety company, concerning Grapefruit’s acquisition of DLC. The Company
LOS ANGELES and DESERT HOT SPRINGS, Calif., April 25, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Grapefruit USA, Inc. (OTCQB: GPFT) (“Grapefruit” or the “Company”), an innovative California-based cannabiotech company, announces today that its cannabis distributor license number C11-0000082-LIC has been renewed through May 13, 2023, by the California Department of Cannabis Control. This the quickest annual renewal for the Company since its original distribution license was issued in January 201
LOS ANGELES and DESERT HOT SPRINGS, Calif., April 19, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Grapefruit USA, Inc. (OTCQB: GPFT) (“Grapefruit” or the “Company”), an innovative California-based cannabiotech company, announces today that its Notice of New Cannabis Product (“NNCP”), filed with Health Canada on Jan. 11, 2022, was approved by Health Canada on March 21, 2022, under NNCP ID No. NP-V2EHUWO907. As a result, Grapefruit is now authorized to sell its patented Hourglass™ Time Release TH